Showing results (201-210 of 336) with videos related to
Sort By:
Pageof 34
British Journal of Haematology|May 29, 2020
The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiencyHanny Al-Samkari, Kathryn Addonizio, Bertil Glader, et al.Journal of Thrombosis and Haemostasis : JTH|October 15, 2025
Validation and clinical application of the hereditary hemorrhagic telangiectasia-specific quality of life scaleHanny Al-Samkari, Raj S Kasthuri, Vivek N Iyer, et al.Journal of Thrombosis and Thrombolysis|August 10, 2016
Treatment of heparin-induced thrombocytopenia before and after the implementation of a hemostatic and antithrombotic stewardship programBrianne M Ritchie, Katelyn W Sylvester, David P Reardon, et al.Blood Cancer Journal|November 6, 2021
Practice patterns and outcomes of direct oral anticoagulant use in myeloproliferative neoplasm patientsJoan How, Charlotte Story, Siyang Ren, et al.Journal of Thrombosis and Thrombolysis|April 9, 2021
Extended duration venous thromboembolism prophylaxis with betrixaban for patients re-admitted with venous thromboembolismMonica Fahmy, Katelyn W Sylvester, Mattia Migliore, et al.Journal of Thrombosis and Thrombolysis|December 24, 2017
Expanding anticoagulation management services to include direct oral anticoagulantsKatelyn W Sylvester, Clara Ting, Andrea Lewin, et al.Journal of Thrombosis and Thrombolysis|February 12, 2015
Implementation of a Hemostatic and Antithrombotic Stewardship programDavid P Reardon, Julie K Atay, Stanley W Ashley, et al.Gastroenterology|December 18, 2019
Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With OutcomesCorinne Frere, Barbara Bournet, Sophie Gourgou, et al.Critical Pathways in Cardiology|December 18, 2020
Atrial Fibrillation Patients on Warfarin and Their Transition to Direct Oral AnticoagulantsPeter Collins, Andrea Lewin, Nicole Vincze Irving, et al.Expert Review of Hematology|June 8, 2026
A call to action for the use of composite hematologic measurements in hereditary hemorrhagic telangiectasia and other chronic bleeding disordersHanny Al-Samkari, Raj S Kasthuri, Jenny Y Zhou, et al.Pageof 34